Tepezza, a thyroid eye disease medication, has been linked with multiple hearing issues, including:
- Permanent hearing loss
- Sensorineural hearing loss (SNHL)
- Ear pain
- Ringing in the ears (tinnitus)
- Autophony (your own voice sounds very loud)
- The feeling of plugged ears
- Dysfunctional Eustachian tube
- Hyperacusis (high sensitivity to sound)
Lawsuits allege that Tepezza has caused hearing issues in people, that Tepezza manufacturer Horizon Therapeutics USA knew or should have known the drug could cause hearing issues, and that Horizon failed to warn about this danger.
Call us today for a free consultation, or text us from this page, if you or a loved one suffered any of the above hearing issues after taking Tepezza. You might be eligible for financial compensation. Our contingency fee lawyers won’t charge you a fee unless and until we obtain financial compensation for you.
2023 Tepezza Lawsuit Updates & Latest News
Oral arguments regarding the establishment of a Tepezza MDL have been scheduled for May 25 in Philadelphia.
34 Tepezza lawsuits have been filed in federal courts as of March 2023. 13 of those cases have seen the filing of voluntary dismissals. This is a sign that those cases might have reached out-of-court settlements.
A motion has been filed to consolidate all Tepezza lawsuits into a multidistrict litigation (MDL). The MDL would be handled in the United States District Court for the Northern District of California.
The lawsuits allege that Horizon knew or should have known the drug could cause hearing loss before submitting the drug for review to United States regulators.